|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.85 EUR | +2.60% |
|
+3.84% | +8.05% |
| 02:02am | Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal | RE |
| 06-10 | Intron Health Upgrades GSK to Hold Rating, Lifts PT | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.65% | +3.73% | +20.71% | +16.74% | +8.61% | +44.35% | +162.12% | +420.87% | +1,480.32% | 1,013B | |
| +0.58% | +5.51% | +8.72% | -0.93% | +16.33% | +55.06% | +50.56% | +45.94% | +106.13% | 574B | |
| +0.80% | +1.01% | +12.05% | -0.21% | -0.56% | +18.65% | +64.97% | +96.85% | +279.13% | 397B | |
| -0.37% | +4.97% | +3.74% | -2.42% | -0.34% | +21.24% | +15.95% | -4.01% | +30.42% | 324B | |
| +0.85% | +0.18% | +0.56% | -6.26% | -1.54% | +24.50% | +14.78% | +62.81% | +254.98% | 280B | |
| +2.10% | +4.92% | +6.90% | +0.25% | +10.89% | +25.30% | +33.80% | +45.87% | +61.84% | 273B | |
| +6.06% | +3.58% | +8.61% | -5.21% | +9.37% | +22.67% | +64.69% | +47.45% | +133.84% | 182B | |
| -0.19% | -0.46% | -5.82% | +13.11% | -13.13% | -45.32% | -48.35% | +9.35% | +55.59% | 194B | |
| +4.26% | -2.03% | -5.21% | -13.32% | +3.11% | +15.79% | +62.55% | +84.03% | +50.70% | 151B | |
| +2.83% | +2.43% | +1.96% | -3.61% | +5.68% | +7.50% | -34.05% | -34.46% | -24.25% | 146B | |
| +2.90% | +1.25% | +2.95% | -4.45% | +6.25% | +14.25% | -11.50% | -14.89% | -20.65% | 114B | |
| +2.20% | +0.72% | +2.24% | -9.64% | -1.86% | -1.66% | +30.63% | +130.51% | +391.42% | 111B | |
| +0.38% | -0.18% | +4.21% | +0.07% | -7.76% | -12.01% | -19.70% | -14.17% | +9.80% | 105B | |
| -1.75% | +0.07% | -5.97% | -21.97% | -9.89% | -2.98% | +87.34% | +74.08% | +484.12% | 77.55B | |
| -0.73% | +6.00% | -3.45% | -11.96% | +4.10% | +15.30% | +10.93% | +33.61% | +10.54% | 49.92B | |
| -0.06% | -0.47% | -11.02% | -16.92% | -21.13% | -14.78% | +2.60% | -35.64% | +225.49% | 45.92B | |
| +1.19% | +0.65% | -3.48% | -10.56% | -3.30% | +28.95% | -29.97% | -33.07% | -59.36% | 40.15B | |
| +3.07% | +0.41% | -3.54% | +13.46% | +10.77% | +99.60% | +372.91% | +211.16% | -35.04% | 39.1B | |
| -1.21% | +1.27% | +2.11% | -8.82% | -10.89% | -16.14% | +3.94% | - | - | 40.13B | |
| Average | +1.34% | +2.60% | +1.91% | -3.82% | +0.25% | +15.80% | +43.90% | +62.57% | +190.83% | 218.78B | |
| Weighted average by Cap. | +1.58% | +3.67% | +8.10% | +1.94% | +4.52% | +25.94% | +63.87% | +136.57% | +460.55% |
- Stock Market
- Stocks
- GSK Stock
- GS71 Stock
- Sector GSK plc
Select your edition
All financial news and data tailored to specific country editions
